MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
3.760
-0.010 (-0.27%)
Nov 4, 2024, 4:00 PM EST - Market closed
MaxCyte Employees
MaxCyte had 143 employees as of December 31, 2023. The number of employees increased by 18 or 14.40% compared to the previous year.
Employees
143
Change (1Y)
18
Growth (1Y)
14.40%
Revenue / Employee
$317,755
Profits / Employee
-$247,762
Market Cap
393.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cross Country Healthcare | 13,131 |
ZimVie | 2,600 |
Sangamo Therapeutics | 405 |
Amylyx Pharmaceuticals | 384 |
Esperion Therapeutics | 240 |
Alpha Teknova | 211 |
Voyager Therapeutics | 162 |
ProQR Therapeutics | 157 |
MXCT News
- 4 days ago - MaxCyte to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 20 days ago - MaxCyte Appoints Cynthia Collins to its Board of Directors - GlobeNewsWire
- 24 days ago - MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 25 days ago - MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer - GlobeNewsWire
- 4 weeks ago - Maxcyte: Reaching Financial Inflection With CASGEVY Ramp Up - Seeking Alpha
- 7 weeks ago - MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases - GlobeNewsWire
- 2 months ago - MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference - GlobeNewsWire
- 3 months ago - MaxCyte, Inc. (MXCT) Q2 2024 Earnings Call Transcript - Seeking Alpha